Developing the system of quality measures for medical care assessment in patients with chronic heart failure: methodology and criteria (review)

Objective: To develop a system of quality measures for monitoring the process and outcome of medical care in patients with chronic heart failure (CHF) in real clinical practice. Review methodology. The procedure for selecting indicators to monitor the treatment of cardiological patients proposed by О M. Posnenkova (2013) was applied. An analysis of the Russian Ministry of Health's clinical guidelines on CHF (2024) was conducted to determine the characteristics of the planned treatment outcomes and key measures with proven impact on outcomes. A systematic literature review using the PRISMA methodology was performed to identify therapeutic interventions that determine the achievement of results in real-world clinical practice. The PubMed and eLibrary databases were used. The search depth was from 2020 to 2024. Twenty-five sources were selected. Conclusion. In real clinical practice it is advisable to assess: 1) the proportion of patients with HF with reduced ejection fraction (EF) who have been prescribed quad-riple therapy (angiotensin-converting enzyme inhibitor/angiotensin receptor/angiotensin receptor neprilysin inhibitors + beta-blockers + aldosterone receptor antagonists + sodium/glucose cotransporter 2 inhibitors); 2) the proportion of patients with HF with preserved EF and HF with mildly reduced EF who have been prescribed sodium/glucose cotransporter 2 inhibitors; 3) the proportion of HF patients without adverse events (hospitalizations due to HF or death) over the past 12 months.